This website is best viewed using the vertical display on your mobile device.

Prof Dr Pierre Coulie

Pierre Coulie is Professor of Immunology, de Duve Institute, Université catholique de Louvain (UCL), Belgium. He obtained his MD in 1982 from the UCL. From here, he trained as an immunologist and became an investigator at the Ludwig Institute from 1989 to 1995, following which he obtained his PhD.

Professor Coulie’s main research interests lie in the field of cancer therapy, melanoma, breast cancer and severe forms of autoimmune disease, including but not limited to rheumatoid arthritis and lupus erythematosus nephritis. He is primarily interested in human anti-tumour immunology in the context of various immunotherapies. In particular, the mechanisms of tumour control observed in some treated patients and the reasons for clinical failure in others. He was Elected At-Large Director, Society for Immunotherapy of Cancer (SITC), Milwaukee, US, and a member of the Board of Directors of the Belgium Immunological Society (BIS) in 2014. In 2016 he became President of the Belgian Foundation Against Cancer. He currently serves on editorial board for Oncoimmunology and Cancer Immunity. From 2006 to 2016, he was also an editorial board member for the European Journal of Immunology. He has been the primary author on five noteworthy publications in peer-reviewed journals.